The North America Coronary Artery Bypass Graft Market should witness market growth of 8.4% CAGR during the forecast period (2023-2029).
The purpose of coronary artery bypass graft surgery is to remove obstructions that impede blood flow. The procedure bypasses blood flow by grafting a vein or blood vessel from the thigh. Depending on the number of blocks, one or more grafts may be employed. CABG surgery is performed to enhance life quality and lessen angina and other cardiovascular illnesses symptoms. The market is driven by an increase in endoscopic procedures, an increase in cardiovascular disease incidence, demographic shifts, comorbidities, including obesity and stress brought on by sedentary lifestyles and an aging population, and a rise in medical tourism.
The main causes of cardiovascular diseases (CVDs) in people include stress, sedentary lifestyles, and junk food consumption. The market is expected to develop faster throughout the projection period due to the rising senior population, which is projected to be a primary driver of more coronary artery bypass graft procedures.
According to CDC data, heart disease remains the primary cause of death for women, men, and most ethnic and racial minorities in the United States. One person dies from cardiovascular disease in the US every 34 seconds. In the United States, heart disease killed 697,000 lives in 2020, accounting for 1 in 5 fatalities. In addition, heart disease cost the US economy about $229 billion in 2017 and 2018. In the United States, healthcare costs have risen dramatically over the previous few decades. In addition, both pricing and demand for medical services have increased due to government programs like Medicare and Medicaid. These factors are anticipated to aid in the regional market's expansion.
The US market dominated the North America Coronary Artery Bypass Graft Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $6,432.6 million by 2029. The Canada market is showcasing a CAGR of 10.9% during (2023-2029). Additionally, The Mexico market would exhibit a CAGR of 9.9% during (2023-2029).
Based on Procedure, the market is segmented into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery. Based on Method, the market is segmented into Off-pump, On-pump, and Minimally Invasive Direct. Based on End-use, the market is segmented into Hospitals, Cardiology Centers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Terumo Corporation, Karl Storz SE & Co. KG, Edwards Lifesciences Corporation, Johnson & Johnson (Ethicon, Inc.), Boston Scientific Corporation, Stryker Corporation, LivaNova PLC, Genesee BioMedical, Inc., and Vitalitec International Medizintechnik GmbH (Peters Surgical)
The purpose of coronary artery bypass graft surgery is to remove obstructions that impede blood flow. The procedure bypasses blood flow by grafting a vein or blood vessel from the thigh. Depending on the number of blocks, one or more grafts may be employed. CABG surgery is performed to enhance life quality and lessen angina and other cardiovascular illnesses symptoms. The market is driven by an increase in endoscopic procedures, an increase in cardiovascular disease incidence, demographic shifts, comorbidities, including obesity and stress brought on by sedentary lifestyles and an aging population, and a rise in medical tourism.
The main causes of cardiovascular diseases (CVDs) in people include stress, sedentary lifestyles, and junk food consumption. The market is expected to develop faster throughout the projection period due to the rising senior population, which is projected to be a primary driver of more coronary artery bypass graft procedures.
According to CDC data, heart disease remains the primary cause of death for women, men, and most ethnic and racial minorities in the United States. One person dies from cardiovascular disease in the US every 34 seconds. In the United States, heart disease killed 697,000 lives in 2020, accounting for 1 in 5 fatalities. In addition, heart disease cost the US economy about $229 billion in 2017 and 2018. In the United States, healthcare costs have risen dramatically over the previous few decades. In addition, both pricing and demand for medical services have increased due to government programs like Medicare and Medicaid. These factors are anticipated to aid in the regional market's expansion.
The US market dominated the North America Coronary Artery Bypass Graft Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $6,432.6 million by 2029. The Canada market is showcasing a CAGR of 10.9% during (2023-2029). Additionally, The Mexico market would exhibit a CAGR of 9.9% during (2023-2029).
Based on Procedure, the market is segmented into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery. Based on Method, the market is segmented into Off-pump, On-pump, and Minimally Invasive Direct. Based on End-use, the market is segmented into Hospitals, Cardiology Centers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Terumo Corporation, Karl Storz SE & Co. KG, Edwards Lifesciences Corporation, Johnson & Johnson (Ethicon, Inc.), Boston Scientific Corporation, Stryker Corporation, LivaNova PLC, Genesee BioMedical, Inc., and Vitalitec International Medizintechnik GmbH (Peters Surgical)
Scope of the Study
By Procedure
- Single CABG Surgery
- Double CABG Surgery
- Triple CABG Surgery
- Quadruple CABG Surgery
By Method
- Off-pump
- On-pump
- Minimally Invasive Direct
By End-use
- Hospitals
- Cardiology Centers
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Terumo Corporation
- Karl Storz SE & Co. KG
- Edwards Lifesciences Corporation
- Johnson & Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Stryker Corporation
- LivaNova PLC
- Genesee BioMedical, Inc.
- Vitalitec International Medizintechnik GmbH (Peters Surgical)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Coronary Artery Bypass Graft Market by Procedure
Chapter 5. North America Coronary Artery Bypass Graft Market by Method
Chapter 6. North America Coronary Artery Bypass Graft Market by End-use
Chapter 7. North America Coronary Artery Bypass Graft Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Medtronic PLC
- Terumo Corporation
- Karl Storz SE & Co. KG
- Edwards Lifesciences Corporation
- Johnson & Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Stryker Corporation
- LivaNova PLC
- Genesee BioMedical, Inc.
- Vitalitec International Medizintechnik GmbH (Peters Surgical)
Methodology
LOADING...
